search
Back to results

Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia

Primary Purpose

Schizophrenia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Active tDCS + Auditory Training
Active tDCS + Control Condition
Sham tDCS + Auditory Training
Sponsored by
VA Greater Los Angeles Healthcare System
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Schizophrenia focused on measuring Transcranial Direct Current Stimulation, tDCS, Auditory Processing, tone matching

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. age 18-65 yrs
  2. At least 3 months since any hospitalization or substantial increase in level of care for an acute exacerbation of psychotic symptoms
  3. At least 6 months since any behaviors suggesting any potential danger to self or others; adherence to the regular administration of an antipsychotic medication if prescribed; dose of antipsychotic medication not varying by more than 25% over the 3 months prior to study participation;
  4. Chronic medical conditions (e.g., hypertension, diabetes, dyslipidemia) consistently treated and stable for at least 3 months prior to study participation;
  5. Ability to provide signed informed consent and to cooperate with study procedures.
  6. Able to understand spoken English sufficiently to comprehend testing procedures

Exclusion Criteria:

  1. History of treatment with electroconvulsive therapy within 6 months prior to study participation;
  2. Documented history of persistent substance use disorder within 6 months prior to study participation
  3. Acute medical problems
  4. Metallic hardware on the scalp
  5. Prior diagnosis of seizure or epilepsy
  6. Subjects requiring proxy consent or consent from a legally authorized representative (LAR)

Sites / Locations

  • West Los Angeles VA Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Active tDCS + Auditory Training

Active tDCS + Control Condition

Sham tDCS + Auditory Training

Arm Description

Cathodal tDCS plus concurrent active auditory training exercise

Cathodal tDCS plus concurrent control condition

Sham tDCS plus concurrent active auditory training exercise

Outcomes

Primary Outcome Measures

tone matching
Performance based measure of tone discrimination

Secondary Outcome Measures

Full Information

First Posted
May 15, 2018
Last Updated
May 6, 2020
Sponsor
VA Greater Los Angeles Healthcare System
search

1. Study Identification

Unique Protocol Identification Number
NCT03537703
Brief Title
Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia
Official Title
Transcranial Direct Current Stimulation and Effects on Early Auditory
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
May 20, 2018 (Actual)
Primary Completion Date
May 1, 2020 (Actual)
Study Completion Date
May 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
VA Greater Los Angeles Healthcare System

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Individuals with schizophrenia have difficulties in functioning in the community. No one really knows what factors determine how well patients manage in the real world. The purpose of this pilot study is to try a new approach to improving a potential determinant of good community functioning, namely how we process sounds. Specifically, the investigators propose to examine the benefit of combining auditory training exercises with transcranial direct current stimulation (tDCS). tDCS is a new tool that is being developed as a safe and noninvasive neurostimulation method, for improving processing of sounds. Transcranial direct current stimulation involves placing a wet sponge electrode on the head and one on the arm. Electrical current from a device powered by a 9-volt battery will flow from one electrode to the other. A small portion of the current will pass through the skull and stimulate the brain. This procedure is non-invasive and painless and it results in increase or decrease of spontaneous neuronal firing in the brain. Neurons are brain cells that send electrochemical messages to each other. Its safety and beneficial effect on mental functions has been demonstrated in healthy individuals and several clinical populations. The purpose of this study is to determine if transcranial direct current stimulation added to auditory training exercises can improve how schizophrenia patients process sound.
Detailed Description
Neuroplasticity is the capacity of the brain to adapt and change in response to stimuli. In schizophrenia, structural and synaptic neuroplastic impairments potentially contribute to early perceptual processing deficits that in turn contribute to downstream higher cognitive dysfunction. The N-methyl-D-aspartate receptor (NMDA-R) hypofunction hypothesis of schizophrenia potentially explains the synaptic neuroplastic impairments as the NMDA receptor is a key component of synaptic plasticity. A rational treatment strategy involves targeting the underlying synaptic neuroplastic and perceptual processing deficits. That is, modulating the capacity for synaptic plasticity and remediating the processing deficits could then cascade into improved perceptual processing and eventually lead to better cognitive functioning. Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique that has been shown to modulate synaptic plasticity. tDCS is promising because the technology is low cost and the treatment is well-tolerated and has a good safety profile. Both human and animal studies have implicated an essential role of the NMDA receptor in tDCS induced neuroplastic changes. Recent animal studies demonstrated that tDCS increased levels of an NMDA-R agonist and induced neuroplastic changes. Cognitive training has been shown to induce both synaptic and structural neuroplastic changes in control and psychiatric patient populations. This approach targets specific neural systems with directed exercises that employ a combination of repetition, reward, and motivation to induce adaptive neuroplastic changes. While both tDCS and cognitive training can induce synaptic plasticity changes, each approach has specific strengths that could converge in a cooperative manner. tDCS modulates NMDA-R activity and creates an environment that enhances the likelihood of synaptic changes to occur. However, tDCS alone has no inherent mechanism that drives change with specificity or directionality. Cognitive training employs targeted and repeated exercises, which confers specificity and directionality to synaptic changes. However, the extent of change that occurs is limited by the impaired state of neuroplasticity in schizophrenia. Conceivably, employing cognitive training in an environment enriched for plasticity could lead to enhanced and adaptive synaptic neuroplastic change. Subjects who have a psychiatric illness and may be cognitively impaired will be included in the study. Persons with schizophrenia commonly have cognitive impairments that affect attention, memory, and executive functioning. There is considerable evidence that these deficits are linked to impairments in social and occupational functioning that are characteristic of the disorder. The cognitive deficits and functional impairments of the illness are the target of interest in the study and therefore this patient population will be the specific targets for subject recruitment. Objectives and Aims The purpose of this proposal is to determine the effect of adding adjunctive cognitive training to tDCS in improving early auditory processing in schizophrenia patients. Specific Aims Determine if adding a cognitive auditory training exercise concurrently to cathodal tDCS offers an advantage to improving early auditory processing over tDCS alone in schizophrenia patients. Determine if adding cathodal tDCS to a cognitive auditory training exercise offers an advantage to improving early auditory processing over auditory training alone in schizophrenia patients. Study Protocol 30 individuals with schizophrenia will be randomly divided into 3 groups. Group 1- Cathodal tDCS + auditory training exercise Group 2- Cathodal tDCS + control condition Group 3- Sham tDCS + auditory training exercise Subjects in Group 1 and 2 will receive cathodal stimulation while Group 3 will receive Sham stimulation. The training component for Groups 1 and 3 will be an active auditory training program while Group 2 will engage in a control condition. On day 1, subjects will receive a baseline Tone Matching Task (TMT) and Mismatch Negativity (MMN) assessment followed by 2 sessions of tDCS. Subjects will received tDCS + training for 20 min followed by a 20 min rest period, and then a second 20 min tDCS + training session. Subjects will return the following day (approximately 21 hrs later) where they will undergo tDCS + training, a 20 min rest, and a final tDCS + training session. The post-stimulation TMT and MMN assessment will be conducted immediately following the final tDCS + training session. Each of these sessions will take approximately 3 hrs hours to complete.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia
Keywords
Transcranial Direct Current Stimulation, tDCS, Auditory Processing, tone matching

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel Assignment
Masking
Participant
Masking Description
Sham tDCS
Allocation
Randomized
Enrollment
35 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active tDCS + Auditory Training
Arm Type
Experimental
Arm Description
Cathodal tDCS plus concurrent active auditory training exercise
Arm Title
Active tDCS + Control Condition
Arm Type
Active Comparator
Arm Description
Cathodal tDCS plus concurrent control condition
Arm Title
Sham tDCS + Auditory Training
Arm Type
Active Comparator
Arm Description
Sham tDCS plus concurrent active auditory training exercise
Intervention Type
Combination Product
Intervention Name(s)
Active tDCS + Auditory Training
Intervention Description
Active tDCS will be cathodal tDCS applied bilaterally over the auditory cortex for 20 min. The auditory training exercise will 20 min of computerized auditory training using the Sound Sweeps module of the Posit Science Brain HQ
Intervention Type
Combination Product
Intervention Name(s)
Active tDCS + Control Condition
Intervention Description
Active tDCS will be cathodal tDCS applied bilaterally over the auditory cortex for 20 min. The control condition will be subjects watching a silent movie for 20 min during active tDCS stimulation.
Intervention Type
Combination Product
Intervention Name(s)
Sham tDCS + Auditory Training
Intervention Description
Sham tDCS will be cathodal tDCS applied bilaterally over the auditory cortex for 1 min with the current then slowly ramped down to 0 amps over the course of another minute. The auditory training exercise will 20 min of computerized auditory training using the Sound Sweeps module of the Posit Science Brain HQ
Primary Outcome Measure Information:
Title
tone matching
Description
Performance based measure of tone discrimination
Time Frame
40 min after last stimulation/training condition

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 18-65 yrs At least 3 months since any hospitalization or substantial increase in level of care for an acute exacerbation of psychotic symptoms At least 6 months since any behaviors suggesting any potential danger to self or others; adherence to the regular administration of an antipsychotic medication if prescribed; dose of antipsychotic medication not varying by more than 25% over the 3 months prior to study participation; Chronic medical conditions (e.g., hypertension, diabetes, dyslipidemia) consistently treated and stable for at least 3 months prior to study participation; Ability to provide signed informed consent and to cooperate with study procedures. Able to understand spoken English sufficiently to comprehend testing procedures Exclusion Criteria: History of treatment with electroconvulsive therapy within 6 months prior to study participation; Documented history of persistent substance use disorder within 6 months prior to study participation Acute medical problems Metallic hardware on the scalp Prior diagnosis of seizure or epilepsy Subjects requiring proxy consent or consent from a legally authorized representative (LAR)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Walter Dunn
Organizational Affiliation
VA Medical Center-West Los Angeles
Official's Role
Principal Investigator
Facility Information:
Facility Name
West Los Angeles VA Medical Center
City
Los Angeles
State/Province
California
ZIP/Postal Code
90073
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia

We'll reach out to this number within 24 hrs